The past two years have eroded the confidence of young researchers, who now question whether years of training will lead to stable careers in American science. This week's election offers a chance to reverse that trend, but only if Congress takes immediate, concrete steps.

Federal research dollars are not just line items — they sustain jobs, fuel discoveries, and train the workforce that private industry depends on. New medicines, technologies, and entire industries often emerge from research whose applications were unforeseeable at the start. Public investment carries that work through years of uncertainty. Losing research capacity weakens the nation's ability to generate future economic growth, a point lawmakers should treat as an economic priority, not just a scientific one.

Read also
Policy
Congress Faces December Deadline to Reverse Science Funding Damage
The election offers a chance to restore confidence in American science, but Congress faces a December 11 deadline to preserve funding and block political interference in grantmaking.

A laboratory takes years to build; once its team disperses, restoring funding cannot instantly restore its expertise. Every delay makes recovery harder and risks wasting the public investment already made. Congress must use its funding and oversight powers to preserve what can still be saved and rebuild what has been lost.

The administration will retain control of research agencies, and funding legislation will remain subject to presidential veto. Congress will need to combine sustained oversight with bipartisan agreements that protect scientific independence and ensure appropriated funds reach researchers. Building that coalition must begin now, and the first deadline arrives before the newly elected Congress takes office in January.

On December 11, the current stopgap funding measure expires, along with its temporary prohibition on the Office of Management and Budget's proposed overhaul of federal grant rules. Congress must preserve research funding and extend that prohibition. Allowing political control over grantmaking to become more deeply entrenched would make recovery considerably harder. The outgoing Congress has an immediate responsibility to act.

Appropriated money must also reach laboratories. In 2025, the Government Accountability Office found that the National Institutes of Health had unlawfully withheld appropriated funds. An award delivered after a research team has dispersed may come too late to save the work. The next funding agreement should require timely grant decisions, protect against politically motivated interruptions, and require agencies to account publicly for withheld funds. Preserving a budget on paper accomplishes little if researchers cannot use it.

A dedicated recovery program should provide emergency bridge funding while suspended or terminated awards receive expedited, independent review. Restart support should cover the actual costs of resuming valuable work, with urgency for long-running studies, irreplaceable biological resources, and teams at risk of dispersing. Extending a grant's deadline will not pay salaries or maintain equipment. Congress should provide recovery funding in addition to regular research budgets, preserving opportunities for new discoveries while repairing disrupted work.

That effort must include rebuilding the agencies responsible for evaluating proposals and delivering awards. Experienced program officers, review staff, and grants administrators are essential to making research funding function. Congress should fund that capacity and require clear schedules for resolving interrupted awards and disbursing recovery support. The next generation deserves particular attention. Even short funding interruptions can alter a young scientist's career. Congress should fund extensions to fellowships and training grants, bridge support for early-career laboratories, and opportunities for displaced researchers to resume their work. Agencies should extend eligibility windows for career development awards, and universities should adjust promotion timelines and protect trainees.

Recovery also requires welcoming scientists from around the world. The federal government must provide predictable visa processes, and research institutions must sustain international collaboration. Talented people have choices about where to build their careers. Attracting and retaining them requires dependable support and confidence that they can pursue their work freely.

Congress must put lasting protections for scientific independence into law. Suspending, terminating, or withholding awards should require documented grounds tied to published criteria and timely access to independent review. Agencies should explain departures from scientific review recommendations. Public reporting, independent audits, and whistleblower protections should help expose political interference and enforce these safeguards. Elected officials have a legitimate responsibility to set broad research priorities and demand accountability. Peer review itself should remain open to improvement. Clear rules can preserve those responsibilities while guarding against the use of research funds as political rewards or punishments — rules that must bind administrations of either party.

Successful recovery will be visible in laboratories: awards delivered on time, valuable research resumed, and young scientists able to complete their training and establish independent careers. Congress should set public benchmarks for those outcomes. Researchers must again be able to plan work that takes years with reasonable confidence that commitments will be honored. The young scientists weighing their futures today will help determine America's future health and prosperity. The election created an opportunity — and the December 11 deadline is the first test of whether Congress will seize it.